EuropaBio - the European Association for Bioindustries

For the next two weeks, we will resume our Exploring Industrial Biotech: The Series. Today we start with microorganisms🦠 Did you know that #microorganisms were the first living creatures on Earth? Microorganisms are invisible to the human eye, but they are essential to life. They are a large family of single or multi-celled organisms including bacteria, fungi and algae. They live in oceans, forests, plants, animals, and in our bodies! 🪸🐬🦩🐈🌱 But why are microorganisms relevant to industrial #biotech? 🟡Microorganisms are like factories. With the right information and ingredients, they can efficiently produce many different kinds of products. 🟡Microorganisms and their derived products such as enzymes are already used at large-scale to produce food (bread, beer, cheese), pharmaceuticals (insulin), consumer products (detergents, cosmetics), biofertilizers, biopesticides, and as building blocks for other industries (bioplastics, biochemicals). Biotechnology products are alternatives to fossil-based products. They are #sustainable and environmentally friendly.

☀That's a wrap on beautiful sunny Brussels!   💬EuropaBio November Council meetings ended today after insightful discussions about biotech across the legislative landscape and setting the expectations for the #BiotechAct!   💡EuropaBio holds its Council meetings three times per year, in March, June and November. It is the moment when its Members gather together to reflect on the work done so far and set the priorities for the upcoming months. See you next spring for the 2025 March Council!

💬 Today EuropaBio - the European Association for Bioindustries & European Forum for Industrial Biotechnology and the Bioeconomy (EFIB) hosted a roundtable discussion as part of #EFIB for EuropaBio members and invited guests.   This discussion brought biotech SMEs, policymakers including from Permanent Representations and the European Commission, and key opinion leaders together. It was an opportunity for SME participants active in the biotech sector to share their main driving forces and obstacles to accessing global markets and supply chains. The session explored the essential elements required to speed up EU market access of #biotech products, covering biotech applications and their impact on the bioeconomy, how biotech can contribute to sustainable agriculture and food security, and the surrounding EU policy landscape.   🔜 Keep an eye out on our page for the dedicated event report that will follow & for more #EFIB events!

Today we are resuming our journey of discovering feedstock and its potential by presenting 6 examples of existing value-chains that start from sustainable feedstock and integrate biotech. 🧬💙 These examples showcase the biomanufacturing of key ingredients that take part in final products that we use and consume daily. Scroll below to find out more ⬇️ And read the full paper at: https://lnkd.in/eQMZts2j

🎉We are delighted to announce that OM Pharma has joined EuropaBio - the European Association for Bioindustries as a new member! EuropaBio Director-General Dr. Claire Skentelbery commented "OM Pharma is an excellent example of Europe’s capacity within healthcare #biotechnology, combining innovation and manufacturing. We are delighted to welcome Christian and the team into EuropaBio at this vital phase of ambition for #biotech within policy, and will bring their voices to help turn ambition into the legislation." We look forward to working with OM Pharma and collaborating towards advancing the biotech sector in Europe. ➡️ Read more here https://lnkd.in/ehG9yWHN

As Commissioner confirmations continue, our DG Dr. Claire Skentelbery sat with Ian Mundell, from Science|Business to comment on EuropaBio - the European Association for Bioindustries expectations for the new Commission portfolio for Start-ups, Research, and Innovation.   The EuropaBio - the European Association for Bioindustries DG said, "We know what Europe must be, compared to the global regions that out-compete us. Our scientific breakthroughs deserve better at EU and member state level,”   ➡ Read the full article at: https://lnkd.in/eXsGy4Jf

🩸🌍 Today, on World Diabetes Day, we celebrate the life-saving role that #biotech & #biomanufacturing continues to play in the role of diabetes management!   💉For over a century, insulin has been essential for millions of patients living with diabetes worldwide. Thanks to biotech & biomanufacturing, insulin is produced in an efficient, safe and scalable way, providing reliable access to this essential medicine.   🎥 Watch our video below to explore how biotechnology & biomanufacturing enables to manufacture insulin more sustainably while ensuring the highest quality standards.

💬 Next week EuropaBio - the European Association for Bioindustries & European Forum for Industrial Biotechnology and the Bioeconomy (EFIB) will be hosting a roundtable discussion as part of #EFIB for EuropaBio members and invited guests. This discussion bringing together SMEs and policymakers will be an opportunity for SME participants active in the sector to share their main driving forces and obstacles to accessing global markets and supply chains. The session will explore the essential elements required to speed up EU market access of #biotech products. 🔜 Stay tuned for the dedicated event report that will follow!

📢 Following the Budapest Declaration, EuropaBio - the European Association for Bioindustries calls Member States to keep the momentum on #biotechnology applications across strategic EU sectors, including health, agri-food and manufacturing. Biotech is a key driver for EU economic and social growth and a New European Competitiveness Deal is essential to lay the ground towards the EU #BiotechAct. ➡ Read our full statement at: https://lnkd.in/eegPkysk

Biotech on the spotlight 🩵🧬🩵🧬🩵🧬   The European Innovation Council and SMEs Executive Agency (EISMEA) placed #biotech as core technology for Europe Platform in their latest 2025 EIC Work Programme.   EuropaBio - the European Association for Bioindustries welcomes the Programme as part of a long-term vision to set an ambitious and competitive European biotech ecosystem. An integrated approach from early research to access to the market is more than needed for biotech and biomanufacturing applications. EuropaBio looks towards the future EU #BiotechAct to complement these financing efforts and ensure the EU environment supports the development and deployment of biotech innovation.   Published a few days ago, the Programme established a funding system to support innovative and resilient sectors advancing EU leader role in solving urgent global challenges. You can find the all document below ⬇️